Table 1 Clinical cases used for electrophysiology and immunohistochemistry.
Pathology | Gender | Age (years) | Duration epilepsy | Seizure types | Brain area | Seizures/month | Mutation | ASMs |
|---|---|---|---|---|---|---|---|---|
1. TSC | m | 47y | 46y | FB/TC | T | > 50 | TSC2 | VPA, CBZ |
2. TSC | f | 17y | 17y | FS | F | > 50 | TSC2 | LEV, VPA, VGB, OXC |
3. TSC | f | 30y | 30y | FS | F | 10–20 | TSC2 | LMT, LEV |
4. TSC | m | 35y | 34y | FB/TC | F | > 50 | TSC2 | LEV, VGB, CLB |
5. TSC | m | 8y | 8y | FS/SE | T | 20–30 | TSC2 | VGB, LMT, CLB |
6. TSC | f | 9y | 9y | FS | F | > 50 | TSC2 | LMT, CBZ |
7. TSC | m | 2y | 2y | FS | F | > 50 | TSC2 | VGB, LEV |
8. GG* | m | 50y | 48y | FS | T | 20–30 | BRAF | LEV, CBZ |
9. GG* | m | 1y | 1 m | FS | T | > 50 | BRAF | LEV |
10. GG* | f | 23y | 1y | FS | T | > 50 | BRAF | LMT |
11. GG | m | 41y | 11y | FS | T | 30–40 | BRAF | LMT, TPM |
12. GG | m | 17y | 2y | FB/TC | F | 20–30 | BRAF | CBZ, CLB |
